Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients

Proteomics - Clinical Applications

Volumn 8, Issue 9-10, 2014, Pages 783-795

  Remily Wood, Elizabeth R ^a   Benson, Kaaron ^a   Baz, Rachid C ^a   Chen, Y Ann ^a   Hussein, Mohamad ^a,b   Hartley Brown, Monique A ^a,c   Sprung, Robert W ^a   Perez, Brianna ^a   Liu, Richard Z ^a   Yoder, Sean J ^a   Teer, Jamie K ^a   Eschrich, Steven A ^a   Koomen, John M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ig quantification; LC MRM MS; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; PEPTIDE; PROTEASOME INHIBITOR; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN VARIABLE REGION;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN CONSTANT REGION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY MULTIPLE REACTION MONITORING MASS SPECTROMETRY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MULTIPLE MYELOMA CELL LINE; NEPHELOMETRY; PATIENT MONITORING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RNA SEQUENCE; TUMOR REGRESSION; AMINO ACID SEQUENCE; BLOOD; CHEMISTRY; COHORT ANALYSIS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA;

EID: 84908051327     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300077     Document Type: Article

References (48)

1. Greipp, P. R., San Miguel, J., Durie, B. G., Crowley, J. J. et al., International staging system for multiple myeloma. J. Clin. Oncol. 2005, 23, 3412-3420.
2. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br. J. Haematol. 2003, 121, 749-757.
3. Durie, B. G., Salmon, S. E., A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975, 36, 842-854.
4. Durie, B. G., Harousseau, J. L., Miguel, J. S., Bladé, J. et al., International uniform response criteria for multiple myeloma. Leukemia 2006, 20, 1467-1473.
5. Koomen, J. M., Haura, E. B., Bepler, G., Sutphen, R. et al., Proteomic contributions to personalized cancer care. Mol. Cell. Proteomics 2008, 7, 1780-1794.
6. Berth, M., Delanghem, J., Langlois, M., Buyzere, M., Reference values of serum IgA subclasses in caucasian adults by immunonephelometry. Clin. Chem. 1999, 45, 309-310.
7. French, M. A. H, Harrison, G., Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin. Exp. Immunol. 1984, 56, 473-475.
8. Haraldsson, A., Kock-Jansen, M., Jaminon, M., van Eck-Arts, P. B. et al., Determination of kappa and lambda light chains in serum immunoglobulins G, A and, M. Ann. Clin. Biochem. 1991, 28, 461-466.
9. Chen, K., Jan, Y., Chen, C., Cheng, C. et al., Multiple myeloma-associated cast nephropathy with crystal structure: case report and review of the literature. Nephrology 2005, 10, 594-596.
10. Buckley, R., Fiscus, S., Serum IgD and IgE concentrations in immunodeficiency diseases. J. Clin. Invest. 1975, 55, 157-165.
11. Hunder, G., Gleich, G., Immunoglobulin E (IgE) Levels in serum and synovial fluid in rheumatiod arthritis. Arthritis Rheum. 1974, 17, 955-963.
12. O'Connell, T. X., Horita, T. J., Kasravi, B., Understanding and interpreting serum protein electrophoresis. Am. Fam. Physician 2005, 71, 105-112.
13. Jolliff, C. R., Blessum, C. R., Comparison of serum protein electrophoresis by agarose gel and capillary zone electrophoresis in a clinical setting. Electrophoresis 1997, 18, 1781-1784.
14. Morita, K., Okamoto, Y., The discrepancy between electrophoretic and nephelometric determinations of serum gamma globulin level. Clin. Lab. 2004, 50, 415-418.
15. Mussap, M., Pietrogrande, F., Ponchia, S., Stefani, P. M. et al., Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis. Clin. Chem. Lab. Med. 2006, 44, 609-611.
16. Schreiber, W. E., Chiang, E., Tse, S. S., Electrophoresis underestimates the concentration of polyclonal immunoglobulins in serum. Am. J. Clin. Pathol. 1992, 97, 610-613.
17. Clark, R., Katzmann, J. A., Kyle, R. A., Fleisher, M. et al., Differential diagnosis of gammopathies by capillary electrophoresis and immunosubtraction: analysis of serum samples problematic by agarose gel electrophoresis. Electrophoresis 1998, 19, 2479-2484.
18. Jagannath, S., Value of serum free light chain testing for the diagnosis and monitoring of monoclonal gammopathies in hematology. Clin. Lymphoma Myeloma 2007, 7, 518-523.
19. Tate, J. R., Mollee, P., Dimeski, G., Carter, A. C. et al., Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin. Chim. Acta 2007, 376, 30-36.
20. Pika, T., Minarik, J., Schneiderka, P., Budikova, M. et al., The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myeloma. Biomed Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 2008, 152, 61-64.
21. Reimer, C. B., Maddison, S. E., Standardization of human imunoglobulin quantitation: A review of current status and problems. Clin. Chem. 1976, 22, 577-582.
22. Barr, J. R., Maggio, V. L., Patterson, D. G., Jr., Cooper, G. R. et al., Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin. Chem. 1996, 42, 1676-1682.
23. Barnidge, D. R., Dratz, E. A., Martin, T., Bonilla, L. E. et al., Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 2003, 75, 445-451.
24. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W. et al., Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 2003, 100, 6940-6945.
25. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
26. Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J. et al., Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell Proteomics 2009, 8, 1860-1877.
27. Keshishian, H., Addona, T., Burgess, M., Kuhn, E. et al., Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6, 2212-2229.
28. Kirsch, S., Widart, J., Louette, J., Focant, J. F. et al., Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J. Chromatogr. A. 2007, 1153, 300-306.
29. Kuhn, E., Wu, J., Karl, J., Liao, H. et al., Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
30. Barnidge, D. R., Goodmanson, M. K., Klee, G. G., Muddiman, D. C., Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J. Proteome Res. 2004, 3, 644-652.
31. Yocum, A. K., Khan, A. P., Zhao, R., Chinnaiyan, A. M., Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer. Proteomics 2010, 10, 3506-3514.
32. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J. et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633-641.
33. Prakash, A., Rezai, T., Krastins, B., Sarracino, D. et al., Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J. Proteome Res. 2010, 9, 6678-6688.
34. Kuhn, E., Addona, T., Keshishian, H., Burgess, M. et al., Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 2009, 55, 1108-1117.
35. Agger, S. A., Marney, L. C., Hoofnagle, A. N., Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. Clin. Chem. 2010, 56, 1804-1813.
36. Hoofnagle, A. N., Becker, J. O., Wener, M. H., Heinecke, J. W., Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin. Chem. 2008, 54, 1796-1804.
37. Evans, V. C., Barker, G., Heesom, K. J., Fan, J. et al., De novo derivation of proteomes from transcriptomes for transcript and protein identification. Nat. Methods 2012, 9, 1207-1211.
38. Remily-Wood, E. R., Liu, R. Z., Xiang, Y., Chen, Y. et al., A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer. Proteomics Clin. Appl. 2011, 5, 383-396.
39. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M. et al., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26, 966-968.
40. Zhang, G., Fang, B., Liu, R. Z., Lin, H. et al., Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity. J. Proteome Res. 2011, 10, 305-319.
41. Martin, D. B., Holzman, T., May, D., Peterson, A. et al., MRMer, an interactive open source and cross-platform system for data extraction and visualization of multiple reaction monitoring experiments. Mol. Cell. Proteomics 2008, 7, 2270-2278.
42. Holm, S., A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6, 65-70.
43. Langmead, B., Trapnell, C., Pop, M., Salzberg, S. L., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10, R25.
44. Trapnell, C., Pachter, L., Salzberg, S. L., TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25, 1105-1111.
45. Grabherr, M. G., Haas, B. J., Yassour, M., Levin, J. Z. et al., Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat. Biotechnol. 2011, 29, 644-652.
46. Alexander, R. L., Jr., Comparison of radial immunodiffusion and laser Nephelometry for quantitating some serum proteins. Clin. Chem. 1980, 26, 314-317.
47. Guiguet, M., Padieu, P., Mack, G., Laser nephelometric measurement of seven serum proteins compared with radial immunodiffusion. J. Clin. Chem. Biochem. 1983, 21, 217-221.
48. Katzmann, J. A., Clark, R. J., Abraham, R. S., Bryant, S. et al., Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection on monoclonal light chains. Clin. Chem. 2002, 48, 1437-1444.